Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malassezia-Induced Type 2 Immunity in Head Neck Shoulder Type Atopic Dermatitis.

Allergy·2026
Same author

Evaluation of a non-auditory neurocognitive test battery in hearing-impaired according to age.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2024
Same author

[Gene-selective treatment approaches for Huntington's disease].

Der Nervenarzt·2020
Same author

ADHD patients fail to maintain task goals in face of subliminally and consciously induced cognitive conflicts.

Psychological medicine·2017
Same author

Immunomodulatory treatments and cognition in MS.

Acta neurologica Scandinavica·2016
Same author

Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.

Journal of neurology·2016

Related Experiment Video

Updated: Jun 26, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Error processing in normal aging and in basal ganglia disorders.

C Beste1, R Willemssen, C Saft

  • 1Institute for Cognitive Neuroscience, Biopsychology, Ruhr University of Bochum, Germany. beste@ifado.de

Neuroscience
|January 27, 2009
PubMed
Summary
This summary is machine-generated.

Normal aging and basal ganglia diseases like Parkinson's and Huntington's disease impact cognitive functions. This study reveals distinct modulations in error processing, suggesting disease effects can override aging impacts.

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice
07:03

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Published on: July 31, 2019

Related Experiment Videos

Last Updated: Jun 26, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice
07:03

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Published on: July 31, 2019

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Gerontology

Background:

  • Aging and basal ganglia diseases share cognitive effects, particularly on medial prefrontal cortex functions.
  • Executive functions, including error processing, rely on basal ganglia and medial prefrontal areas like the anterior cingulate cortex (ACC).

Purpose of the Study:

  • To investigate if normal aging and basal ganglia diseases differentially modulate error processing functions.
  • To compare error processing mechanisms in young and elderly controls, and patients with Parkinson's and Huntington's disease.

Main Methods:

  • Utilized a cognitive event-related potential (ERP) known as the error negativity (ERN) to assess error processing.
  • Included extended samples of young controls, elderly controls, Parkinson's disease patients, and Huntington's disease patients.

Main Results:

  • Modulations in error processing were found to differ between normal aging and different basal ganglia diseases.
  • Parkinson's and Huntington's disease groups exhibited similar error processing modulations, suggesting pathogenic effects override aging.
  • Basal ganglia diseases appear to impact error processing more significantly than normal aging alone.

Conclusions:

  • Comparing aging with various basal ganglia disorders provides insights into age- and disease-related cognitive mechanisms.
  • Diseases of the basal ganglia can profoundly affect error processing, potentially exceeding the impact of normal aging.
  • This study integrates findings across aging, Parkinson's, and Huntington's disease concerning error processing.